English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

American Cancer Society Cancer Action Network

+ Regulatory
Press release submission | Jul 31, 2018

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: Massachusetts Joins Ranks of States Preventing Tobacco Sales to Youth Under 21, Becomes First State to Pass Tobacco Sale Ban

+ Regulatory
Press release submission | Jul 25, 2018

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: ACS CAN Letter: Drug Pricing Policy Should Prioritize Patient Affordability

+ Regulatory
Press release submission | Jul 4, 2018

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: State Bills Limiting Local Authority Could Threaten Future Public Health Policies

+ Regulatory
Press release submission | Jun 28, 2018

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: Association Health Plan Rule Likely to Divide Insurance Market; Strip Patient Protections

+ Regulatory
Press release submission | May 29, 2018

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: Patient Safety in Jeopardy Under Senate Right-to-Try Proposal

+ Regulatory
Press release submission | May 22, 2018

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: New Law Regulating ‘Step Therapy’ Puts Patients First

+ Regulatory
Press release submission | May 8, 2018

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: American Cancer Society Cancer Action Network Testifies Against Medicaid Work Requirement Legislation

Press release submission | Apr 26, 2018

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: CDC Launches New Round of Powerful Tobacco Cessation Ads

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • 1
  • 2
  • 3
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily